Phase 1b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Repeated Doses of DB-020 in Patients Receiving Cisplatin
Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DB-020 in Healthy Volunteers
100 Clinical Results associated with Decibel Therapeutics Australia Pty Ltd.
0 Patents (Medical) associated with Decibel Therapeutics Australia Pty Ltd.
100 Deals associated with Decibel Therapeutics Australia Pty Ltd.
100 Translational Medicine associated with Decibel Therapeutics Australia Pty Ltd.